These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6098109)

  • 41. [Persistence of the tick-borne encephalitis and Langat viruses in mouse thymocytes in experimental infection against a background of cyclophosphane-induced immunodepression].
    Vargin VV; Semenov BF
    Vopr Virusol; 1985; 30(5):577-81. PubMed ID: 3000083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines].
    Vorob'eva MS; Rasshchepkina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):35-7. PubMed ID: 1301660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains].
    Leonova GN; Pavlenko EV
    Vopr Virusol; 2010; 55(3):33-7. PubMed ID: 20608079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of macrophages in the pathogenesis of experimental tick-borne encephalitis in mice.
    Khozinsky VV; Semenov BF; Gresíková M; Chunikhin SP; Sekeyová M; Kozuch O
    Acta Virol; 1985 May; 29(3):194-202. PubMed ID: 2864820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
    Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory].
    Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus].
    Sokolova ED; Kamalov II; Konovalov GV
    Vopr Virusol; 1994; 39(5):220-3. PubMed ID: 7716907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events.
    von Hedenström M; Heberle U; Theobald K
    Vaccine; 1995; 13(8):759-62. PubMed ID: 7483792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Features of immunogenesis in simians infected with attenuated strains of tick-borne encephalitis and Langat virus].
    Levkovich EN; Karpovich LG; Larina GI; Shermukhamedova DA
    Vopr Virusol; 1981; (2):160-4. PubMed ID: 6267819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
    Klockmann U; Bock HL; Kwasny H; Praus M; Cihlová V; Tomková E; Krivanec K
    Vaccine; 1991 Jan; 9(1):42-6. PubMed ID: 2008800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
    Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
    Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Protective and damaging action of cytotoxic T-lymphocytes in experimental tick-borne encephalitis].
    Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):56-60. PubMed ID: 6967662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis.
    Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB
    Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
    Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.